A retrospective and single-center study evaluated thyroid functions and IL-6 levels in 287 COVID-19 cases admitted in non-intensive care units (NICU) and the results revealed that COVID-19 could significantly correlate with a high risk of thyrotoxicosis due to the systemic immune activation that is commonly induced by the SARS-CoV-2 viral infection [5].